De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial

作者：Daniel Ma, Katharine A. R. Price, Eric J. Moore, Samir H. Patel, Michael L. Hinni, David M. Routman, Briant F. Fruth, Nathan R. Foster, Kathryn M. Van Abel, Linda X. Yin, M.A. Neben-Wittich, Yolanda I. Garces, L.A. McGee, Scott C. Lester, Jean‐Claude M. Rwigema, Adam L. Holtzman, Daniel L. Price, Jeffrey R. Janus, Jan L. Kasperbauer, Ashish Vittalrao Chintakuntlawar, Joaquin Garcia, Robert L. Foote · 发表于：The Lancet Oncology · 年份：2025 · DOI：10.1016/s1470-2045(25)00324-9 · 被引用次数：26 · 研究领域：Head and Neck Cancer Studies、Esophageal Cancer Research and Treatment、Colorectal and Anal Carcinomas